On March 11, 2020, our firm filed an application for authorization to bring a class action against Coloplast. This request aims to obtain compensation for our customers as well as for all persons who have suffered damage as a result of the implantation of a transvaginal mesh product manufactured, distributed or sold by Coloplast.
Target group
All persons residing in Quebec who have used transvaginal mesh products manufactured, marketed, distributed and/or sold in whole or in part by the defendant (Aris, Exair, Minitape, Novasilk, Omnisure, Restorelle Direct Fix Anterior, Restorelle Direct Fix Posterior, Supris, T-Sling) and who allegedly suffered damage as a result of the implantation of these mesh products.
What is a transvaginal mesh product?
Transvaginal mesh products are also called pelvic mesh products, vaginal mesh, transvaginal mesh, surgical mesh, surgical strip or suburethral strip, hammock or sling.
These surgical devices are used during pelvic surgery for patients with pelvic organ prolapse (POPs) or stress urinary incontinence (SUI).
In February 2010, Health Canada issued an advisory to hospitals regarding complications associated with the implantation of transvaginal mesh products.
In May 2014, Health Canada issued an advisory to hospitals regarding the safety of transvaginal mesh products.
Serious complications associated with mesh products include: vaginal and urethral erosion, pain including dyspareunia, infection as well as perforations of adjacent organs.
Current status of the file
The parties came to a settlement.
On March 11, 2026, the Court approved the closing of this file. To read the judgment (in French), click here.
How do I be part of the class action?
If you fall within the definition of the class that is the subject of this class action, you are automatically part of the class action.